Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 13,702.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 13,702.4% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,151.52% |
TMC the metals (TMC) | 722.81% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 462.55% |
Centrus Energy (LEU) | 449.6% |
Opendoor Technologies (OPEN) | 400.92% |
Forward Industries (FORD) | 392.43% |
Mercurity Fintech Holding Inc ADR (MFH) | 371.51% |
Ramaco Resources (METC) | 355.87% |
Ondas (ONDS) | 319.6% |
Cidara Therapeutics (CDTX) | 308.56% |
ViaSat (VSAT) | 303.64% |
GRAIL, LLC (GRAL) | 299.16% |
Planet Labs PBC (PL) | 282.89% |
Energy Fuels (UUUU) | 275.24% |
Celcuity LLC (CELC) | 274.21% |
Applied Digital (APLD) | 273.12% |
Cipher Mining (CIFR) | 271.69% |
Sandisk (SNDK) | 269.88% |
Uniqure (QURE) | 256.58% |
American Bitcoin (ABTC) | 229.15% |
Sibanye Gold Ltd ADR (SBSW) | 228.15% |
SSR Mining (SSRM) | 224.57% |
DRDGOLD Limited ADR (DRD) | 224.36% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
